Update in unfractionated heparin, low-molecular-weight heparins, and heparinoids in the elderly (age >/= 65 years).
Spinler
S A
SA
The Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, PA 19104, USA.
Evans
C M
CM
D000368:Aged / Q000502:physiology*; D000369:Aged, 80 and over; D006493:Heparin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D006496:Heparinoids / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D006801:Humans
D006495:Heparin, Low-Molecular-Weight; D006496:Heparinoids; D006493:Heparin